Chiral Chemicals Market Research Report—Global Forecast till 2030

Chiral Chemicals Market Research Report Information By Technology (Traditional Separation Method, Asymmetric Preparation Method, Biological Separation Method) Application (Pharmaceutical, Agrochemical, Flavors and Fragrances, Others) Forecast 2030

ID: MRFR/CnM/3509-CR | May 2022 | Region: Bric | 100 Pages         

Chiral Chemicals Market Speak to Analyst Request a Free Sample

Chiral chemicals Market

The Global chiral chemicals market was valued at USD 58,762.6 million in 2021 and is expected to register a CAGR of 11.25% to reach USD 147,668.2 million by the end of 2030.

Segmentation
By Technology Traditional Separation Method Asymmetric Preparation Method Biological Separation Method
Application Pharmaceutical Agrochemical Flavors and Fragrances Others
Key Players
Companies Profiled   BASF (Germany)   Solvias AG (Germany)   Stern Chemicals Inc. (United States)   Johnson Matthey Plc (United Kingdom)   W. R. Grace & Co.-Conn. (US)   Chiral Quest (Suzhou) Co.Ltd. (China)   Tyche Industries Limited (India)   Nanjing Legend Pharmaceutical (China)   The Dow Chemical Company (US)   Flamma S.p.A. (Italy)
Drivers
Market Driving Forces   Surge in demand from the pharmaceutical industry
Request a Free Sample

Chiral chemicals Market Overview


The Global chiral chemicals market was valued at USD 58,762.6 million in 2021 and is expected to register a CAGR of 11.25% to reach USD 147,668.2 million by the end of 2030.


A compound which exhibits chirality that is not superimposable on its mirror images is called as chiral compound. It comprises of carbon atom at center attached with four different substitutes. The right hand and left-hand configurations are called as enantiomers. In addition, the stereo center of chiral molecule may not be only carbon atom, it may also consist of tetravalent phosphorus and trivalent sulphur compounds. Enantiomers possess same physical properties, but difference exist in direction of rotation. The prominent application of chiral compound is in pharmaceutical industry. Owing to its effects and superior properties, chiral chemicals used in pharmaceutical industry differs in pharmacology and effects on biological organisms. Commercially, the separation of enantiomers is difficult and usually separated by different processing methods such as traditional, asymmetric and biological method. Over the forecast period, traditional separation method to remain largest dominating technology segment.


COVID-19 Impact on the Chiral chemicals Market:


The outbreak of COVID-19 has significantly impacted the chemicals & materials supply chains, international trade, and manufacturing operations across the world. As a result of a lockdown across geographies, the production facilities have faced disruptions. The market players have had to shut production facilities or operate the facilities below the optimal production capacities to avoid the spread of COVID-19. All this has caused severe disruptions in production and trade restrictions, significantly affecting the supply of Chiral Chemicals into the market. According to the United Nations, the global economy is projected to contract by around 3% or more instead of registering a 2.5% growth projected by the World Economic Situation and Prospects report 2020.


Chiral Chemicals play a vital role in the production of pharmaceuticals and agrochemicals. Since these industries come under essential services, some of the large players have continued operations at their production facilities while taking preventive measures such as practicing social distancing, remote working when possible, and enforcing travel restrictions. Looking at the global scenarios, various governments have lifted restrictions and allowed ease for the supply of Chiral Chemicals. Further, various manufacturers have focused on developing innovative products to counter COVID-19.


Market Dynamics


Drivers

  • SURGE IN DEMAND FROM THE PHARMACEUTICAL INDUSTRY


Chirality has a major role in the synthesis and development of drugs. About more than half of the drugs currently in use are chiral compounds. The pharmacological activity of drugs depends mainly on their interaction with biological targets such as proteins, nucleic acids, and biomembranes. Chiral drugs include glucuronide, tramadol, capreomycin, glutathione, ketamine, thiopentone, isoflurane, enflurane, desflurane, atracurium, mepivacaine, bupivacaine, atropine, isoproterenol, paracetamol, levocetirizine, and dobutamine. Henceforth, the growth of the global pharmaceutical industry and increasing demand for drugs are expected to propel the growth of the global chiral chemicals market during the forecast period.


Restraints

  • GOVERNMENT REGULATIONS ON CHIRAL PESTICIDES


Pesticides’ toxic effects on the environment are becoming common because 25% of pesticides contain chiral chemicals. The growing number of patents on chiral pesticides and other agrochemical products has put regulatory bodies under pressure to assess chiral pesticides’ ecotoxicity. Furthermore, the insecticides and herbicides mentioned above pose unpredictable ecological risks, causing problems for both humans and the environment.  


Opportunity

  • BIOCATALYTIC SYNTHESIS OF CHIRAL CHEMICALS


Chiral chemicals are a group of chiral synthons to synthesize products, drugs, agrochemicals, and various other non-pharmaceutical applications. The conventional synthetic approach is inefficient in material usage and requires a large number of organic solvents with high toxic metals, resulting in high energy intensive capitalization. The adoption of biocatalytic beneficial technology would take the chemical industry at the forefront to meet the country’s economic development.


Segmentation


By Technology



  • Traditional Separation Method

  • Asymmetric Preparation Method

  • Biological Separation Method


By Application



  • Pharmaceutical

  • Agrochemical

  • Flavors and Fragrances

  • Others


Regional Analysis


North America accounted for a significant market share and is projected to exhibit a healthy CAGR over the forthcoming years. Asia-Pacific is the expected to drive the product demand due to growing pharmaceutical industry in South Asia. Over the next five years, the Southeast Asian pharmaceutical market is expected to increase at an annual rate of more than 11%, with sales reaching USD 40 billion in 2020. As a result, it has become one of the world’s fastest expanding pharmaceutical markets. The region provides lucrative opportunities for pharmaceutical companies that can effectively synergize good manufacturing practices (GMP) standards, competitive pricing, and an export strategy. Pharmaceutical companies in South Asia will profit from rising healthcare spending, an aging population, greater incidence of lifestyle-related diseases coupled with a rising GDP per capita. According to the World Health Organization (WHO), 13% of the population (10.3 million people) is currently above the age of 60. By 2025, the elderly will account for 25% of the population. Indonesian and Malaysian demographics are following a similar trend.


Competitive Landscape


The competitive landscape offers an analysis of the key developments by the companies operating in the global market. The global chiral chemicals market is expected to exhibit a healthy CAGR during the forecast period. The growth of the global market is primarily driven by the widespread use of persulfate in major end-use industries such as polymer, electronics, water treatment, personal care and cosmetics industry, and others. Some of the major players operating in this market include BASF (Germany), Solvias AG (Germany), Stern Chemicals, Inc. (United States), Johnson Matthey Plc (United Kingdom), W. R. Grace & Co.-Conn. (US), Chiral Quest (Suzhou) Co.Ltd. (China), Tyche Industries Limited (India), Nanjing Legend Pharmaceutical (China), The Dow Chemical Company (US), and Flamma S.p.A. (Italy). However, major global companies like BASF, The Dow Chemical Company, Solvias AG, and W.R. Grace & Co. cater product portfolio of chiral chemicals according to application industries such as pharmaceutical, agrochemical, and flavor & fragrances.


Supply Chain Analysis


The supply chain analysis enables the reader to comprehend the steps and stakeholders involved in the process of manufacturing and distribution of chiral chemicals. The supply chain of the chiral chemicals market comprises raw material suppliers, chiral chemicals manufacturers, distribution channels, and end-use. The primary raw materials for manufacturing chiral chemicals are enzymes and catalysts and chiral intermediates such as lactams, epoxides, peptides, diols, and amines. Chiral chemicals used in pharmaceuticals gain momentum in cephalosporin and penicillin as they are widely sold to generic drug providers. Dipeptides used in artificial sweeteners and phenoxy propionic in pesticides are some of the non-pharmaceutical chiral chemicals.


Report Overview:


The Chiral chemicals market is segmented by type, application, end use and region in the report. In terms of insights, this report has focused on various levels of analysis such as market dynamics, value chain analysis, Porter's five forces, competitive landscape, and company profiles—all of which comprise and discuss views on the global chiral chemicals emerging and fast-growing segments, regions, and countries.


Objectives of the Study



  • To get a comprehensive overview of the global Chiral chemicals market

  • To get wide-ranging information about the key factors driving the market and market opportunities

  • To gain information regarding the key players in the industry, their product portfolio, strategies, and key developments

  • To gain insights about the key country/region in which the market is growing


Intended Audience



  • Pharmaceutical Industry

  • Agrochemical Industry

  • Food Industry

  • Research Institutes

  • Academic Institutes

  • Government Organizations



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 147,668.2 Million
  CAGR   11.25% CAGR (2022-2030)
  Base Year    2021
  Forecast Period   2022 to 2030
  Historical Data   2019 & 2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, and Application
  Geographies Covered   North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa
  Key Vendors   BASF (Germany), Solvias AG (Germany), Stern Chemicals, Inc. (United States), Johnson Matthey Plc (United Kingdom), W. R. Grace & Co.-Conn. (US), Chiral Quest (Suzhou) Co.Ltd. (China), Tyche Industries Limited (India), Nanjing Legend Pharmaceutical (China), The Dow Chemical Company (US), and Flamma S.p.A. (Italy).
  Key Market Opportunities   Biocatalytic synthesis of chiral chemicals
  Key Market Drivers   Surge in demand from the pharmaceutical industry


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global Chiral chemicals market would register a growth of 11.25%.

The pharmaceutical industry will play a prominent role in taking the market forward.

Government regulations on chiral chemicals could restrain the market.

North America would enjoy the upper hand in the Chiral chemicals market.